Our study provides evidence that ANGPTL4 overexpression in pancreatic cancer impacts several key signaling and metabolic pathways associated with patient survival, in part through controlling cellular resistance to chemotherapy and cellular migration. This evidence concerns the gene ANGPTL4 and familial pancreatic carcinoma.